Lung Diseases Research
Small Business Innovation Research (SBIR) program: To expand
Small Business Technology Transfer (STTR) program: To stimulate and foster scientific and technological innovation through cooperative research and development carried out between small business concerns and research institutions; to foster technology transfer between small business concerns and research institutions; to increase private sector commercialization of innovations derived from Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation.
- Cardiovascular Diseases Research
- Blood Diseases and Resources Research
- National Center on Sleep Disorders Research
Examples of Funded Projects
(1) An individual research grant to investigate basic mechanisms of primary pulmonary hypertension, a lethal disease that causes progressive obstruction of small pulmonary arteries.
This grant has established a national registry of familial primary pulmonary hypertension that is providing the framework for linkage analysis and the molecular search for basic mechanisms of this disease.
(2) A multi-project grant dealing with cellular and molecular mechanisms underlying acute and chronic asthma.
The focus of this program is on the mechanisms causing asthma in humans.
The work includes laboratory projects, animal research, and human studies.
The work includes laboratory projects and animal research concentrated on the cellular pathways of the asthmatic inflammatory process, focused on the mast cell, a critical cell type in asthma.
(3) A Specialized Center of Clinically Oriented Research (SCCOR) grant in Translational Research in Acute Lung Injury.
This grant consists of several projects that combine basic and clinical research with the goal of improving the outcome of patients with Acute Lung Injury.
The investigators are studying novel mechanisms and treatments for this syndrome.
The grant includes a clinical trial of Activated Protein C, to inhibit coagulation and inflammation, a study to identify the role of transforming growth factor B1 as a mechanism underlying the disease and a novel study of genetic factors that might increase susceptibility in patients with severe pneumonia and acute lung injury.
The program includes genetic, proteomic, and molecular biological approaches in addition to the clinical trial.
(4) An individual National Research Service Award to study the effect of the interruptions in breathing during sleep caused by sleep apnea.
The investigator will study the expression of genes in response to intermittent hypoxia and sustained hypoxia, which cause pulmonary vasoconstriction and systemic vasodilation.
The research training and coursework received under the award will provide a foundation of skills the investigator will use to study the deleterious effect of intermittent hypoxia on the cardiopulmonary system.
(5) A Small Business Technology Transfer Program for development of a Thermal HydroSeal (THS) system that will allow surgeons to seal air leaks that arise on the raw lung surface exposed during a lobectomy.
Surgical resections, are common procedures in lung cancer patients.
Postoperative air leakage at the parenchymal surfaces following lung resections, is a frequent complication which can result in extended hospital stays.
The development of this device will be useful to pulmonary physicians, providing them with an effective system to seal air leaks, which should improve patient recovery and reduce hospital stays.
- Continuation of Existing Grant Based Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01)
- Stimulating Access to Research in Residency (StARR) (R38)
- Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)
- Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research (R21)
- Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)
The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
Relevant Nonprofit Program Categories
Program Accomplishments
In fiscal year 2007, 1,213 research grants and 106 National Research Service Awards were made. The estimates for fiscal year 2008 are 1,213 research grants and 106 National Research Service Awards. The estimates for fiscal year 2009 are 1,213 research grants and 106 National Research Service Awards. In fiscal year 2007, for new and competing renewal awards: 1,595 grant applications were received, and of these, 319 were awarded; 200 National Research Service Award applications were received, and of these, 42 were awarded. Small Business Innovation Research/Technology Transfer Awards: In fiscal year 2007, 16 Phase I awards and 13 Phase II awards were made.
Uses and Use Restrictions
Grants may support salaries, equipment, supplies, travel, and patient hospitalization as required to perform the research effort.
Restrictions or limitations are imposed against the use of funds for entertainment, foreign travel, general-purpose equipment, alterations and renovations, and other items not regularly required for the performance of research.
National Research Service Awards (NRSAs) are made directly to individuals for research training in specified biomedical shortage areas.
Grants may be made to institutions to enable them to make NRSAs to individuals selected by them.
Certain service and payback provisions apply to individuals upon termination of the award.
SBIR Phase I grants (of approximately 6-months' duration) are to establish the technical merit and feasibility of a proposed research effort that may lead to a commercial product or process.
Phase II grants are for the continuation of the research initiated in Phase I and which are likely to result in commercial products or processes.
Only Phase I awardees are eligible to apply for Phase II support.
STTR Phase I grants (normally of 1-year duration) are to determine the scientific, technical, and commercial merit and feasibility of the proposed cooperative effort that has potential for commercial application.
Phase II funding is based on results of research initiated in Phase I and scientific and technical merit and commercial potential on Phase II application.
Eligibility Requirements
Applicant Eligibility
Any nonprofit organization engaged in biomedical research, as well as institutions or companies organized for profit, may apply for grants with the exception of NRSAs.
An individual may apply for a NRSA or, in some cases, may qualify for a research grant if adequate facilities in which to perform the research are available.
SBIR grants can be awarded only to domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed and have no more than 500 employees).
Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project.
In both Phase I and Phase II, the research must be performed in the U.S.
and its possessions.
To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.
STTR grants can be awarded only to domestic small business concerns (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed and have no more that 500 employees) which "partner" with a research institution in cooperative research and development.
At least 40 percent of the project is to be performed by the small business concern and at least 30 percent by the research institution.
In both Phase I and Phase II, the research must be performed in the U.S.
and its possessions.
To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.
Beneficiary Eligibility
Any nonprofit or for-profit organization, company or institution engaged in biomedical research. Only domestic for-profit small business firms may apply for SBIR and STTR programs.
Credentials/Documentation
Applicants for individual National Research Service Awards must be citizens of the United States or have been admitted for permanent residency; must hold a doctoral degree (M.D., Ph.D., D.D.S., D.O., D.V.M., Sc.D., D. Eng., or equivalent domestic or foreign degree); and must designate a desire for training in one of the health or health-related areas specified by the National Institutes of Health. Each applicant must be sponsored by an accredited public or private nonprofit institution engaged in such training. Costs will be determined in accordance with OMB Circular No. A-87 for State and local governments. For-profit organizations' costs are determined in accordance with Subpart 31.2 of the Federal Acquisition Regulations. For other grantees, costs will be determined in accordance with HHS regulations 45 CFR, Part 74, Subpart Q. For SBIR and STTR grants, applicant organization (small business concern) must present in a research plan an idea that has potential for commercialization and furnish evidence that scientific competence, experimental methods, facilities, equipment, and funds requested are appropriate to carry out the plan. Grant forms PHS 6246-1 and PHS 6246-2 are used to apply for SBIR Phase I and Phase II, respectively. Grant forms PHS 6246-3 and PHS 6246-4 are used to apply for STTR Phase I and Phase II, respectively.
Aplication and Award Process
Preapplication Coordination
Not applicable.
This program is excluded from coverage under E.O.
12372.
Application Procedures
Research grant applications are submitted on designated forms to the Center for Scientific Review, National Institutes of Health, Bethesda, MD 20892. Forms for individual NRSA applications may be obtained from and submitted to the Office of Research Manpower, Center for Scientific Review, National Institutes of Health, Bethesda, MD 20892. For some special grant programs, applicants may be advised to submit directly to the Review Branch, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, Bethesda, MD 20892. The standard application forms, as furnished by PHS and required by 45 CFR, Part 92, must be used for this program. SBIR and STTR Grant Solicitations and SBIR Contract Solicitation may be obtained electronically through the NIH's "Small Business Funding Opportunities" home page at www.nih.gov/grants/funding/sbir.htm on the World Wide Web. A limited number of hard copies of these publications are produced. Subject to availability, they may be obtained by contacting the NIH support services contractor: Telephone: (301) 206-9385; Fax: (301) 206-9722; E-mail: a2y@cu.nih.gov. The Solicitations include submission procedures, review considerations, and grant application or contract proposal forms. SBIR and STTR grant applications should be submitted to the Center for Scientific Review, 6701 Rockledge Drive, Room 1040 - MSC 7710, Bethesda, MD 20892-7710.
Award Procedures
All accepted applications are evaluated by an appropriate initial review group (study section). All grant applications receive a final secondary review by the National Heart, Lung, and Blood Advisory Council. Staff informs applicants of the results of the review. If support is contemplated, staff initiates preparation of awards for grants. All accepted SBIR/STTR applications are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by a national advisory council or board. All applications receiving a priority score compete for available SBIR/STTR set-aside funds on the basis of scientific and technical merit and commercial potential of the proposed research, program relevance, and program balance among the areas of research.
Deadlines
New Research Grants: February 1, June 1, and October 1 (or as specified in Request for Applications (RFA) announcements). Renewals and Supplementals: March 1, July 1, and November 1. Institutional NRSAs: January 10 and May 10. Individual NRSA: April 5, August 5, and December 5. SBIR and STTR Grants: April 1, August 1, and December 1.
Authorization
Public Health Service Act, Section 301, 422 and 487, as amended, Public Laws 78-410 and 99-158, 42 U.S.C. 241, 42 U.S.C. 285, and 42 U.S.C. 288, as amended; Small Business Research and Development Enhancement Act of 1992, Public Law 102-564.
Range of Approval/Disapproval Time
Regular Grants: From 7 to 9 months. SBIR/STTR Grants: About 7-1/2 months.
Appeals
A principal investigator (P.I.) may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH home page www.nih.gov/grants/guide/1997/97.11.21/n2.html.
Renewals
Renewal applications are reviewed in the same manner as new applications.
Assistance Considerations
Formula and Matching Requirements
This program has no statutory formula or matching requirements.
Length and Time Phasing of Assistance
The Advisory Council may recommend funding for periods from 1 to 5 years. Funding commitments are made annually. SBIR: Normally, Phase I awards are for 6 months; normally, Phase II awards are for 2 years. STTR: Normally, Phase I awards are for 1 year; normally, Phase II awards are for 2 years.
Post Assistance Requirements
Reports
Annual reports on progress and expenditures.
Final reports are required within 120 days of termination.
Reports are required after termination of National Research Service Awards to ascertain compliance with the service and payback provisions.
Audits
In accordance with the provisions of OMB Circular No. A- 133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Nonprofit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials.
Records
Expenditures and other financial records must be retained for 3 years from the day on which the grantee submits the last financial status report for the report period.
Financial Information
Account Identification
75-0872-0-1-552.
Obigations
(Grants) FY 07 $582,448,863; FY 08 est $582,448,863; and FY 09 est $582,448,863.
Range and Average of Financial Assistance
$41,250 to $1,042,563; $409,686. Small Business Innovation Research/Small Business Technology Awards: Phase I - $100,000; Phase II - up to $750,000 for STTR and up to $750,000 for SBIR.
Regulations, Guidelines, and Literature
42 CFR 52; 42 CFR 66; 45 CFR 74; 45 CFR 92; "NIH Guide for Grants and Contracts, and Supplements"; PHS Grants Policy Statement, DHHS Publication No. (OASH) 94-50,000, (Rev.) April 1, 1994; Grants will be available under the authority of and administered in accordance with the PHS Grants Policy Statement and Federal regulations at 42 CFR 52 and 42 U.S.C. 241; Omnibus Solicitation of the Public Health Service for Small Business Innovation Research (SBIR) Grant and Cooperative Agreement Applications. Omnibus Solicitation of the National Institutes of Health for Small Business Technology Transfer (STTR) Grant Applications.
Information Contacts
Regional or Local Office
None.
Headquarters Office
Program Contacts: Dr. James Kiley, Director, Division of Lung Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Public Health Service, Department of Health and Human Services, Bethesda, MD 20892, Telephone: (301) 435-0233. Small Business Innovation Research Program: Mrs. Ann Rothgeb, Program Specialist, Airway Biology and Disease Program, Division of Lung Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Public Health Service, Department of Health and Human Services, Bethesda, MD 20892. Telephone: (301) 435-0202. Grants Management. Contact: Ms. Suzanne White, Grants Management Officer, Grants Operations Branch, Division of Extramural Affairs, National Heart, Lung and Blood Institute, National Institutes of Health, Public Health Service, Department of Health and Human Services, Bethesda, MD 20892. Telephone: (301) 435-0144. Use the same numbers for FTS.
Criteria for Selecting Proposals
The major elements in evaluating proposals include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the scientific, technical, or technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific and technical merit of the proposed approach for achieving the Phase II objectives; (3) the qualifications of the proposed principal investigator, supporting staff, and consultants; (4) the technological innovation, originality, or societal importance of the proposed research; (5) the potential of the proposed research for commercial application; (6) the reasonableness of the budget requested for the work proposed; (7) the adequacy and suitability of the facilities and research environment; (8) The adequacy of plans to include both genders and minorities and their subgroups as appropriate for the scientific goals of the research. Plans for the recruitment and retention of subjects will be evaluated; and (9) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment.
Social Entrepreneurship
Spotlight
The Social Innovators of 2014
For 2014, the Schwab Foundation for Social Entrepreneurship has recognized 37 individuals for their outstanding work in the field of social enterprise.
